| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.022 | 0.8 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | -0.0099 | 0.8 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | -0.0093 | 0.8 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | 0.038 | 0.8 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |